Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Planned sale Chief Operating Officer sold 62,180 shares at $5.00 ($310,900)
  2. 4 Planned sale See Remarks sold 15,000 shares at $5.30 ($79,500)
  3. 4 Grant or award Chief Commercial Officer acquired 25,000 shares (grant or award)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 10,819 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes SVP Sales and Marketing gave up 2,714 shares (to pay taxes)
  12. 4 Grant or award SVP, Regulatory Affairs acquired 20,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Shares withheld for taxes Chief Science Officer gave up 32,862 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Operating Officer gave up 17,540 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 18,929 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Medical Officer gave up 8,115 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP Sales and Marketing gave up 5,428 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Legal Officer gave up 20,250 shares (to pay taxes)
  20. 4 Shares withheld for taxes See Remark gave up 14,305 shares (to pay taxes)

Page 4 of 17 · 326 filings